These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3756880)

  • 1. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
    Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
    Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line.
    Wier ML; Scott RE
    Cancer Res; 1985 Jul; 45(7):3339-46. PubMed ID: 4005857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of differentiation control in transformed 3T3 T proadipocytes.
    Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
    Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation.
    Estervig DN; Minoo P; Tzen CY; Scott RE
    J Cell Physiol; 1990 Mar; 142(3):552-8. PubMed ID: 2312615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation.
    Filipak M; Sparks RL; Tzen CY; Scott RE
    J Cell Physiol; 1988 Nov; 137(2):367-73. PubMed ID: 3192620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonterminally differentiated cells express decreased growth factor responsiveness.
    Hoerl BJ; Scott RE
    J Cell Physiol; 1989 Apr; 139(1):68-75. PubMed ID: 2708458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to neoplastic transformation induced by nonterminal differentiation.
    Estervig DN; Maercklein PB; Scott RE
    Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation.
    Wier ML; Scott RE
    J Cell Biochem; 1987 Feb; 33(2):137-50. PubMed ID: 2437134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells.
    Sparks RL; Strauss EE; Zygmunt AI; Phelan TE
    J Cell Physiol; 1991 Jan; 146(1):101-9. PubMed ID: 1990013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aproliferin: a modulator of proliferative potential.
    Wier ML; Scott RE
    Biofactors; 1988 Jul; 1(2):129-31. PubMed ID: 3076440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated control of proliferation and differentiation of mesenchymal stem cells.
    Filipak M; Estervig DN; Tzen CY; Minoo P; Hoerl BJ; Maercklein PB; Zschunke MA; Edens M; Scott RE
    Environ Health Perspect; 1989 Mar; 80():117-25. PubMed ID: 2647473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
    Shekhar MP; Werdell J; Tait L
    Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metaplastic change in mesenchymal stem cells induced by activated ras oncogene.
    Tzen CY; Filipak M; Scott RE
    Am J Pathol; 1990 Nov; 137(5):1091-102. PubMed ID: 2240160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of anticancer activity induced by cellular differentiation.
    Maercklein PB; Estervig DN; Scott RE
    Lab Invest; 1990 Feb; 62(2):196-201. PubMed ID: 2304332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer, retrodifferentiation, and the myth of Faust.
    Uriel J
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4269-75. PubMed ID: 61805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.
    Sell S; Pierce GB
    Lab Invest; 1994 Jan; 70(1):6-22. PubMed ID: 8302019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo.
    Strobel O; Dor Y; Stirman A; Trainor A; Fernández-del Castillo C; Warshaw AL; Thayer SP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4419-24. PubMed ID: 17360539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary control of proliferation and differentiation of Leydig cells and their putative precursors in immature hypophysectomized rat testis.
    Dombrowicz D; Sente B; Reiter E; Closset J; Hennen G
    J Androl; 1996; 17(6):639-50. PubMed ID: 9016394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plate-induced tumors of BALB/3T3 cells exhibiting foci of differentiation into pericytes, chondrocytes, and fibroblasts.
    Boone CW; Scott RE
    J Supramol Struct; 1980; 14(2):233-40. PubMed ID: 7230806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia.
    Scott RE; Florine DL
    Am J Pathol; 1982 Jun; 107(3):342-8. PubMed ID: 7081388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.